1. Home
  2. FGEN vs FCUV Comparison

FGEN vs FCUV Comparison

Compare FGEN & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • FCUV
  • Stock Information
  • Founded
  • FGEN 1993
  • FCUV 2012
  • Country
  • FGEN United States
  • FCUV United States
  • Employees
  • FGEN N/A
  • FCUV N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • FCUV Industrial Machinery/Components
  • Sector
  • FGEN Health Care
  • FCUV Industrials
  • Exchange
  • FGEN Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • FGEN 33.5M
  • FCUV 27.6M
  • IPO Year
  • FGEN 2014
  • FCUV N/A
  • Fundamental
  • Price
  • FGEN $7.45
  • FCUV $2.83
  • Analyst Decision
  • FGEN Strong Buy
  • FCUV
  • Analyst Count
  • FGEN 1
  • FCUV 0
  • Target Price
  • FGEN $250.00
  • FCUV N/A
  • AVG Volume (30 Days)
  • FGEN 48.5K
  • FCUV 20.5K
  • Earning Date
  • FGEN 08-05-2025
  • FCUV 08-13-2025
  • Dividend Yield
  • FGEN N/A
  • FCUV N/A
  • EPS Growth
  • FGEN N/A
  • FCUV N/A
  • EPS
  • FGEN N/A
  • FCUV N/A
  • Revenue
  • FGEN $6,996,000.00
  • FCUV $408,887.00
  • Revenue This Year
  • FGEN N/A
  • FCUV N/A
  • Revenue Next Year
  • FGEN N/A
  • FCUV N/A
  • P/E Ratio
  • FGEN N/A
  • FCUV N/A
  • Revenue Growth
  • FGEN N/A
  • FCUV 6.49
  • 52 Week Low
  • FGEN $4.50
  • FCUV $1.50
  • 52 Week High
  • FGEN $33.49
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 55.79
  • FCUV 29.91
  • Support Level
  • FGEN $7.31
  • FCUV $2.68
  • Resistance Level
  • FGEN $7.82
  • FCUV $3.16
  • Average True Range (ATR)
  • FGEN 0.59
  • FCUV 0.28
  • MACD
  • FGEN 0.10
  • FCUV -0.08
  • Stochastic Oscillator
  • FGEN 69.35
  • FCUV 25.38

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: